Introduction
Guidelines have been defined as 'Statements that include recommendations intended to optimize patient care. They are informed by a systematic review of evidence and an assessment of the benefits and harms of alternative care options' (Institute of Medicine, 2011) . According to Konstantinides et al (2014) , they summarize and evaluate all available evidence at a point in time on a particular issue aiming to assist healthcare workers in selecting the best strategies for patient management. Guidelines can positively change practice and patient outcome; they promote beneficial interventions while discouraging those that are ineffective or possibly dangerous. However, they do not in themselves authorize or outlaw treatment options (Grimshaw et al, 2004; Pantin et al, 2006; Bateman & Saha, 2007) .
The practitioner has to decide when to use a specific guideline, taking their patients' preference(s) in to consideration. Thus, the practitioner should seek the opinion of his/ her patient before using a particular guideline. When used appropriately, guidelines make healthcare more consistent and efficient (Woolf et al, 1999; Pantin et al, 2006; Bateman & Saha, 2007) . There is evidence in the literature to suggest that successful implementation of guidelines reduces mortality and morbidity (Lindsay et al, 2014; Griesdale et al, 2015; Lee et al, 2015) . It has also become more prevalent for guidelines to influence government spending on health (Durieux et al, 2000) .
For the 2017 fiscal year, lower-middle-income and uppermiddle-income economies are separated at a gross national income (GNI) per capita of $4035 (The World Bank, 2016) . Several countries in Africa such as Cameroun, Ghana, Kenya and Nigeria are lower-middle income countries (LMICs) (The World Bank, 2016) . The World Bank estimates that there is an average of 0Á8 doctors per 1000 population in LMICs compared to an average of 2Á9/1000 in HICs (The World Bank, 2011) . The ratio of doctors in the United Kingdom (a high income country, HIC) per 1000 population is estimated to have risen from 2 to 2Á4 between the year 2000 and 2006 (Mayor, 2008) , which is three times higher than the LMIC average. The lack of doctors in LMICs is made worse by brain drain, with a large proportion of doctors (and nurses) trained in these countries emigrating to HICs (Johnson, 2005) . It is estimated that 14Á4% of doctors practicing in the United Kingdom obtained their primary medical qualification in India, Pakistan and Nigeria (http://www. gmc-uk.org/doctors/register/search_stats.asp, accessed 16 November 2016). The rather low GNI, scarcity of doctors and poor healthcare infrastructure result in either absence or unequal distribution of basic healthcare services in LMICs (Lindsay et al, 2014) .
Guideline development and review in LMICs
In most LMICs, there is a paucity of appropriately designed guidelines to assist healthcare workers in their care of patients in specialties such as haematology; as a result, healthcare workers in these countries depend on guidelines developed in more affluent HICs. This may be because healthcare workers in LMICs lack the resources or/and skills to develop local guidelines (Mounesan et al, 2013) . In the absence of local guidelines, those developed by international organizations, such as the World Health Organization (WHO), professional bodies like the British Society for Haematology (BSH) or charitable organizations, such as the World Federation of Haemophilia (WFH) are frequently used. Though these guidelines may be available, it is difficult to determine how widely they are used in LMICs. While the use of guidelines produced by international organizations and professional bodies may be helpful, there is evidence to support the fact that local guidelines are more likely to be implemented than those developed elsewhere (Bateman & Saha, 2007) .
In the absence of local guidelines, doctors and allied healthcare workers in LMICs are faced with the dilemma of identifying a source of guidelines that are relevant and applicable to their specific clinical setting. However, there isn't any standard approach that a practitioner can use to assess the quality of guidelines. The Appraisal of Guidelines for Research and Evaluation (AGREE) instruments seems to be designed primarily for guideline developers and researchers as opposed to end-users (Grimmer et al, 2014) . Feedback from HICs suggests the AGREE instrument is not appropriate in a busy clinical setting with regards to the complexity of the scoring system and requirement for multiple testers to make a judgment on guideline quality (Grimmer et al, 2014) .
There is little or no documentation on the process for developing or updating guidelines in resource poor countries (Agweyu et al, 2012; Vernooij et al, 2014) . To be reliable, guidelines must be relevant and reflect state-of-the art medical practice (Goyet et al, 2014) . Other factors to be considered in guideline development include acceptability and the financial implications of implementing a new guideline (Davino-Ramaya et al, 2012) . There is a tendency for policymakers in LMICs to ignore or mistrust the quality and capacity of local research, paying more attention to research carried out in HICs, which may not be applicable to LMICs (Goyet et al, 2014) . If guidelines developed in HICs are to be used in LMICs, then the collaborators should include local experts; this will help overcome the previously documented challenge of limited stakeholder involvement in the development of guidelines (Tavender et al, 2011; Alarcon et al, 2013) . Involvement of local stakeholders may improve the rates of implementation by identifying and removing barriers to their use, as there is a close association between stakeholder involvement, applicability and guideline implementation (Patel et al, 2016) .
Guidelines developed in collaboration with local experts should include suggestions on how they can be adapted for use in local situations (Patel et al, 2016) . Adaptation of existing guidelines to local environments may be a more costeffective means of providing high-quality guidelines (Fervers et al, 2006) . However, this alternative requires careful planning to avoid additional costs to end-users (Harrison et al, 2013) . If a guideline requires a resource not widely available in LMICs, alternatives will be required, such as the use of latex balloons in place of incentive spirometry devices for preventing and treating acute chest syndrome in patients with sickle cell disease (SCD) (Asare et al, 2016; Patel et al, 2016) . The successful development of guidelines requires improved knowledge on the effectiveness of existing local and cultural practices; local experts should be able to set priorities and ask relevant research questions that will make such guidelines more applicable (Tol et al, 2014; Israels et al, 2015) .
Guidelines should not be too rigid because this may lead to regimented care (Kane et al, 2016) . It is also recommended that the final guideline drafts be reviewed by experts not involved in preparing the guidelines (Vernooij et al, 2014) and should, as much as possible, include local experts. Even if local experts are included in guideline development, the end users in LMICs must assess their validity before implementing them and not see them as 'magic bullets' that will solve all their problems by improving healthcare delivery. It is however, not certain if healthcare workers in LMICs are willing and able to carry out this needed assessment (Feder et al, 1999) .
There are very few haematologists in LMICs to assess, modify and implement haematology guidelines developed in HICs. The few haematologists available are overburdened with clinical, laboratory and teaching responsibilities and may not have time to spend on guideline development and assessment. Ghana has less than 10 haematologists serving a population of over 25 million and according to the Africa Society for Blood Transfusion (AFSBT); in 2011, Nigeria had only 50 haematologists serving a population of 140 million (Obinna, 2011) . This is inadequate when compared to over 1600 haematologists practicing in the United Kingdom with a population of about 65 million (http://www.gmc-uk.org/ doctors/register/search_stats.asp, accessed 16 November 2016).
Applicability of guidelines to LMICs
While it is generally agreed that guideline implementation has a positive influence, for guidelines to be successfully implemented, they must be applicable to the specific environment, based on factors such as availability and cost of required resources, specialized skills, population needs and values (Patel et al, 2016) . Guidelines developed by international organizations and professional societies are not easily consulted on the wards or in clinics because they may be voluminous and as a result become inconvenient and time consuming to use. Again, they may require specialist equipment or knowledge that may not be readily available in most LMICs. For example the BSH guideline on the management of acute chest syndrome in SCD recommends that hospitals have a referral pathway to high dependency and intensive care units . However, few hospitals in LMICs, including the tertiary hospitals in urban areas, have functional high dependency and/or intensive care units (Towey & Ojara, 2007) . Again, the 2014 European Society of Cardiology (ESC) guideline recommends the use of computed tomography angiography or bedside transthoracic echocardiography in the diagnosis of suspected pulmonary embolism in a patient with shock or hypotension (Konstantinides et al, 2014) . These diagnostic modalities are not widely available in most hospitals in LMICs. Where they are available, it may take several hours, if not days, to carry out the procedures on patients who require them.
Even when the guidelines are developed with the LMICs population in mind, they may not still be applicable. For example an intensive regimen for treating Burkitt lymphoma developed by the French-African Paediatric Oncology Group had to be replaced with a less intensive one due to the toxic side effects on patients (Harif et al, 2008) .
The efficacy of low dose recombinant factor VIII (rFVIII) prophylaxis in patients with severe haemophilia A has been reported (Yao et al, 2016) . This is encouraging, as it would enable haematologists working in LMICs extend and expand the limited supply of rFVIII. However, before this can be implemented in LMICs, patients with haemophilia will first have to be diagnosed and the severity of the disease determined. Then a reliable, affordable and steady supply of rFVIII will need to be identified. Currently, virtually all the rFVIII used in most LMICs is donated by the WFH, with long periods between donations when recombinant factor is not available. Without these donations, it will be almost impossible for any patient in LMICs to receive recombinant clotting factors.
Determining the severity of haemophilia is challenging in LMICs. Factor assays can only be carried out in laboratories located in the large tertiary hospitals in the major cities. Even in these laboratories there are periods when they run out of FVIII and FIX deficient plasma; during which they have to rely on deficient plasmas prepared in-house. While these may be helpful in making a diagnosis of haemophilia, they can be unreliable in determining the severity of the disease, since they may not contain <1 iu/dl, as required by the WFH (Srivastava et al, 2013) and the levels of other clotting factors may also be impaired.
The Glivec â International Patient Assistance Program (GIPAP), supported by a pharmaceutical company and the Max Foundation, is responsible for free supply of tyrosine kinase inhibitors to patients with chronic myeloid leukaemia (CML) in LMICs (The Max Foundation, 2016) . These and other donations from HICs enable patients in LMICs benefit from effective guidelines containing targeted therapy used for the management of diseases in HICs, such as CML. Based on an estimated worldwide incidence of 1 in 10 000 births for haemophilia, it is expected that there should be about 2500 patients living with haemophilia in Ghana, which has a population of 25 million (Srivastava et al, 2013) . However, the Ghana Society for Haemophilia currently has less than 200 haemophilia patients on its register; this is a very low number even after making adjustments for a relatively high mortality rate, especially in childhood. Some patients have never had the severity of their disease estimated while very few have had the presence of an inhibitor confirmed, even when this is suspected by the presence of prolonged activated partial thromboplastin time that is not corrected by mixing studies.
Guidelines from HICs are primarily designed with their citizens or residents in mind, mostly based on evidence from HICs whose populations differ from those found in most LMICs. These guidelines are developed by experts drawn from within their country or other HICs Hunt et al, 2015; Watson et al, 2015) . These experts may not be aware of the healthcare needs in LMICs, facilities available to healthcare workers there or the challenges they face. Again, there are differences in socio-demographic, cultural, economic and, possibly, genetic characteristics between the citizens of most HICs compared with those in LMICs. These differences will have a bearing on the successful implementation of guidelines developed in HICs in a less resourced country. Also, the search criteria for evidence used to develop guidelines in HICs often include only publications written in English Hunt et al, 2015) . Research evidence published in other languages, such as French, Portuguese and Arabic (which are widely spoken in many LMICs), may not be considered even when such research findings more closely mirror the healthcare practices in these countries (Al-Rawah & Lee, 2015) . Similarly, English is the language of choice for reporting guideline implementation events making them unavailable to countries where English is not the predominant language (LaGrone et al, 2016) . For these to be used in LMICs, translation to the official languages spoken in specific countries will be required.
While it is very likely that individual health care workers in many LMICs may use guidelines developed in HICs due to the absence of locally applicable alternatives, it is not clear if such guidelines were intended for use outside the country where they were designed; even more so in LMICs. They may not only lack relevance but may also not be applicable to LMICs without significant modifications (Patel et al, 2016) . Guidelines produced in HICs are often resource neutral and are likely to be unworkable in LMICs with less developed infrastructure and resource deficits. Development of evidence-based guidelines oriented specifically for LMICs will be an important step towards improving the health care systems in these countries. Even though these 'local' guidelines may recommend use of strategies different from those used in HICs, they will be aimed at achieving the best standard of care that is practicable in LMICs (Anderson et al, 2006; Gopal et al, 2012) .
Implementation
To improve the availability of clinical practice guidelines, and in a bid to standardize healthcare practices, the WHO and other bodies publish several guidelines every year: however, publication of guidelines does not translate to implementation (Latosinsky et al, 2007) . Improvement in the rate of implementation is affected by several factors, including awareness of the guidelines by policy makers, incorporation of the guidelines into educational curricula and continued systemic needs assessment based on the guidelines (LaGrone et al, 2016) .
Research from LMICs on guideline implementation is scarce (Dua et al, 2011) . In Uganda, it was reported that there was widespread support for guidelines although implementation of such guidelines was predicted to be faced with critical barriers (Kane et al, 2016) . LMICs have greater challenges and barriers to the implementation of guidelines compared to HICs and these need to be surmounted to enable them benefit from guidelines (Patel et al, 2016) . Financial barriers may limit the implementation of guidelines due to additional costs of procuring relevant equipment or the need for further training (Tol et al, 2014) . In some circumstances, the cost of guideline development and implementation may outweigh potential benefits (Grimshaw et al, 2004; Baradaran-Seyed et al, 2013) .
Changing clinical practice in line with guideline recommendations requires multifactorial strategies to address barriers to implementation (Ploeg et al, 2007) . The inclusion of stakeholders from inception is more likely to result in successful guideline implementation (McGrath et al, 2009 ). Cultural adaptation of guidelines is very important (Yip et al, 2008; Kane et al, 2016) . This, in addition to the credibility and acceptability of guidelines to fit the local environment has been found to increase the probability of implementation (Knaup et al, 2009; Chakkalakal et al, 2013; Tol et al, 2014) . Efforts at disseminating guidelines to LMICs must be clear on their flexibility and include ways of adapting them to the local context (Kane et al, 2016 ). Early inclusion of higher level providers, such as specialists in implementation strategies, is also associated with a greater likelihood of acceptance of the modifications outlined by the guidelines (Chakkalakal et al, 2013) .
Research priorities in LMICs should focus on determining the applicability of guidelines to their local environment while guideline dissemination and implementation should be monitored and evaluated continuously. Governments in LMICs will need to invest more in training health workers to address the shortage in human resources (Kane et al, 2016) .
In a bid to improve the supply of well-trained specialist doctors in the West African sub-region, the West African College of Physicians and West African College of Surgeons, which were initially involved in training of specialists for Anglophone West Africa, have expanded their training programmes into the French speaking West African countries. Similarly, the government of Ghana established the Ghana College of Physicians and Surgeons in 2003. These colleges, along with the College of Surgeons of East, Central and Southern Africa and the Nigeria Postgraduate Medical College, play a large role in postgraduate medical training in sub-Saharan Africa. Though there are numerous challenges associated with recruitment of doctors, training and funding; doctors trained by these institutions continue to offer high quality service in their various countries. These specialists should play a key role in guideline development and implementation as stakeholders. Furthermore, the establishment of these colleges provide avenues for collaboration and twinning arrangements with medical postgraduate training institutions in HICs.
Even where and when implementation of guidelines is relatively widespread, the use of guidelines in formulating policies that have the greatest potential impact is often limited. (LaGrone et al, 2016) ; in line with this, it has been reported that WHO guidelines are generally associated with weak stakeholder engagement (Burda et al, 2014) .
Challenges to guideline implementation in LMICs
There are several barriers to guideline implementation in LMICs and these tend to be common across countries and clinical areas (Puchalski et al, 2016) . Gamell et al (2013) reports that there is generally a slow uptake of guidelines in LMICs, which may result from lack of mutual understanding between guideline content developers and policymakers (Fretheim et al, 2006; Goyet et al, 2014) . This is shown by the fact that policymakers in LMICs tend to ignore research carried out in their respective countries in favour of research evidence from HICs, which may not be applicable in a resource challenged environment (Goyet et al, 2014) . The inability to implement guidelines remains a challenge to the development of health systems in many LMICs (Panisset et al, 2012) . The ability to assess health systems for barriers and facilitators to implementation of guidelines may create another financial obstacle that many LMICs may not be able to surmount (Puchalski et al, 2016) .
The resource challenge
It is difficult to implement guidelines in LMICs partly because of the poor health care systems in these countries. Poorly developed infrastructure along with other resource constraints limit uptake of guidelines, ultimately leading to the impairment of clinical practice. This lack of material and human resources in LMICs has been well documented (Puchalski et al, 2016) and is a key barrier to guideline implementation. Sometimes resource shortages can be both actual and relative. For example, inappropriate distribution may lead to scarcity of a specific resource in some departments while they are available in other departments within the same hospital (Puchalski et al, 2016) . Before most guidelines developed in HICs can be implemented in LMICs there needs to be improvement in the quality of facilities for adequate diagnosis and treatment (Barker et al, 2011) , this will require governments in LMICs to spend more on health. In a study from southern Africa, the diagnosis of malignancies was made using only clinical criteria in almost 50% of patients, most likely due to limited pathology diagnostic support (Slone et al, 2014) .
In some countries, policymakers have come to understand that developing good relationships with guideline researchers reduced the mutual mistrust and was an important way to facilitate knowledge transfer (Innvaer et al, 2002) . Involving local health specialists in guideline development may also prevent recommendations that call for expensive and unaffordable treatments (Goyet et al, 2014) .
Due to the lack of healthcare facilities in LMICs, patients have to travel long distances over rough terrain to access health care: as a result, patients who lack the financial capability to pay for transportation or/and accommodation will not be able to benefit from any guideline that is implemented as part of routine medical practice (Nsimba & Kayombo, 2008; Iroezi et al, 2013) . This is one of the reasons for the abandonment of treatment in patients being managed for haematological and other malignancies (Slone et al, 2014) .
Challenges faced by clients
In some LMICs, significant sections of the populace hold on to their traditional and cultural beliefs about health care and the aetiology of diseases (Nsimba & Kayombo, 2008; Iroezi et al, 2013; hIarlaithe et al, 2014) . As a result, they either do not understand the advice received from health workers or, in some cases, simply do not trust them. This tends to negatively affect implementation (Puchalski et al, 2016 ). Research at the client level should be aimed at increasing knowledge on the effectiveness of existing cultural practices, taking into account where feasible the peculiarities of various tribes within a particular country (Kane et al, 2016) . For example, while prenatal diagnosis of SCD and the offer of selective therapeutic abortion is acceptable in most HICs, this is not culturally acceptable to a large proportion of the populace (including healthcare workers) in LMICs such as Nigeria (Durosinmi et al, 1995; Kagu et al, 2004) . With this understanding, a more culturally sensitive method for preventing the inheritance of SCD, such as pre-marital counselling and testing, may be more acceptable and effective in LMICs.
The cost of anticancer agents is virtually beyond the reach of the majority of the populace in LMICs; added to this is the indirect cost of supportive management, such as antibiotics, transfusions and loss of income (Vanderpuye & Yarney, 2014) . A large proportion of those who begin a course of anticancer treatment default and are unable to complete it (Israels et al, 2015) . In a report from Zambia, over 45% of patients abandoned their anticancer treatment for various reasons (Slone et al, 2014) . Another study from South Africa (an upper middle income country), estimated the cost of transfusion required by children treated for cancer to range from $121Á00 to $9424Á00. The same study reported the average cost of treating a child for acute lymphoblastic leukaemia to be $68 000Á00 (Murray & Stefan, 2011) .
The unavailability of cytotoxic drugs often forces the oncologists in LMICs to modify the treatment regimen administered, which ultimately leads to poorer outcomes with treatment failure (Gopal et al, 2012; Slone et al, 2014) .
Thus, whatever guideline is designed for use should be feasible for implementation taking into consideration the available drugs (Israels et al, 2015) . Along with chemotherapy, surgery and radiotherapy that are often given prominence; caregivers of patients with malignancies and other chronic haematological diseases in LMICs require counselling, including spiritual support, to enable them deal appropriately with the disease (Israels et al, 2015) . This will have to be repeated over several sessions and in a language that the caregiver(s) and patient understand to enable them process the diagnosis, prognosis of the disease, treatment costs and side-effects of treatment as well as the treatment goal.
Challenges faced by healthcare professionals
There is scarcity of qualified healthcare workers in most LMICs and this tends to affect guideline implementation (Ansong et al, 2013) . In addition, due to poor infrastructural development, the sharing of information among health workers is poor, especially in rural areas where provision of electricity and internet services is patchy at best (Eamer & Randall, 2013) . There are also reduced opportunities for the few workers available to develop themselves by acquiring new skills through training and continuous professional development courses (Wasunna et al, 2008; Ansong et al, 2013) . Due to the exorbitant cost of specialized care, such as cancer therapy, it is almost impossible for oncologists in LMICs to adhere to guidelines without carrying out some modifications (Kingham et al, 2013; Vanderpuye & Yarney, 2014) .
Another reason for modifying the cancer treatment guidelines in LMICs is that children with malignancies such as Burkitt lymphoma are often malnourished at diagnosis. This reduces their tolerance for anticancer agents and, at the same time, they are at increased risk for severe infections during treatment; this is compounded by late presentation with advanced stage disease. So the intensity of treatment has to be reduced to avoid drug toxicity because supportive care may not be readily available (Harif et al, 2008; Israels et al, 2015) . Low dose hydroxycarbamide has also been tried in adults with SCD in a bid to prevent toxicities, with promising results (Akingbola et al, 2016) .
Palliative care is largely unavailable in LMICs (Delgado et al, 2010; Gopal et al, 2012) . This is not helped by barriers to provision of morphine and other opioids (Ansong et al, 2013; Lebaron et al, 2014) .
Failure to distribute new or revised guidelines to clinicians will lead to a lack of awareness and poor implementation of guidelines. Poor knowledge about how guidelines are developed, how they are assessed for quality and who developed them is a challenge that could lead to lack of trust in validity of the guidelines by healthcare workers (Puchalski et al, 2016) .
Just like the patients, healthcare workers may also let their personal beliefs and local custom influence their judgement while implementing guidelines. For example, it is widely believed that administering the recommended doses of opioids for pain will lead to tolerance or/and dependence (Ansong et al, 2013) . Another instance is role confusion among different cadres of health workers, such as between nurses and doctors; laboratory technologists and laboratory physicians (pathologists); clinical psychologists and psychiatrist (Dowling et al, 1996) . For example, laboratory technologists in some LMICs insist on drawing up guidelines for the running of the clinical laboratories without any input from the pathologists. In others, the technologists (who are more in number) have been known to take laboratory physicians to court over who should be in charge of the laboratory (Okoghenun, 2016) . The role of 'specialist nurses' is also not clear: are they nurses? Or are they going to carry out the duties of medical officers or primary care doctors? (Dowling et al, 1996) . While this has been largely resolved in most HICs, the tension and distrust that role confusion can create is just beginning to be seen in LMICs. This often comes about due to task shifting and is associated with poor communication within and across various cadres of health workers as well as lack of inter-professional collaboration (Puchalski et al, 2016) . This lack of collaboration goes a long way to disrupt attempts at putting together the multidisciplinary teams required to implement guidelines designed for managing medical conditions, such as SCD, haemophilia and malignancies (Srivastava et al, 2013; Israels et al, 2015) .
Another challenge is the difficulty in getting healthcare workers to change their practice to that recommended by the guideline. To achieve this, guideline developers will do well to study how evidence-based interventions may best be adapted for diverse LMIC settings (Tol et al, 2014) . They should also remember that changes in guidelines or introduction of new guidelines take time to be accepted, thus healthcare practices may be slow to change (Nkonki et al, 2007) .
Conclusion
Available evidence points to the fact that guidelines, when implemented appropriately, improve patient outcome. To achieve this in LMICs, guidelines need not only to be evidence-based; they should also be economically feasible and culturally acceptable to the country or region of implementation (Anderson et al, 2006) . However, guidelines designed and developed for use in HICs may not have taken the unique economic, infrastructural and manpower challenges found in LMICs in to consideration. These guidelines are also often developed for populations that are culturally different. These differences make it difficult to implement guidelines developed for HICs in LMICs. To increase the rates of successful implementation, it is necessary for guidelines developed in well-resourced countries to be adapted for use in LMICs. To achieve this, institutions and professional bodies in LMICs should be encouraged to take the lead in guideline adaptation while governments should endeavour to provide avenues for development of local skilled manpower and improve the infrastructure available for health.
The human immunodeficiency virus (HIV) pandemic that swept over most of the developing world during the last 3 decades has left in its wake a relatively robust and successful health care system for the diagnosis and management of people living with HIV/acquired immunodeficiency virus syndrome (AIDS). This has demonstrated that it is possible to organize quality health care systems using applicable clinical practice guidelines in relatively poor regions of the world through interactions between HICs and LMICs (Slone et al, 2014) . The global response to HIV led to provision of healthcare capacity in areas where they had never existed while negotiations with the pharmaceutical industry led to provision of generic antiretroviral drugs at a fraction of their original cost (Gopal et al, 2012) . This has made the care of people living with HIV/AAIDS a reality in LMICs. It should be possible to make similar arrangements for anticancer agents, including hydroxycarbamide as well as recombinant clotting factors.
Such interactions have led to twinning relationships between centres in both HICs and LMICs, with the goal of improving care of patients in LMICs specifically through better management of malignancies. These interactions are designed to include education, mentoring and funding (Strother et al, 2013; Israels et al, 2015) . Such arrangements make it easier for modifications to be made to treatment guidelines, making use of available local facilities and expertise that can subsequently be built on. Guidelines and other interventions that result from such twinning relationships are more likely to be sustainable (Israels et al, 2015) . However, even in the face of inadequate implementation, guidelines could be used as a type of road map to define goals that will help improve facilities over time (Lindsay et al, 2014) . 
